The New Hepatitis C (2^nd Ed.) Effective Clinical Management in the Age of All-Oral Therapy Oxford American Infectious Disease Library Series

Fueled in part by the opioid epidemic, the number of reported hepatitis C virus infections tripled in the United States between 2010 and 2015. As new infections continue to mount, new therapies have produced seismic changes in how HCV is treated clinically, leaving a gap between the most current clinical guidance and the ongoing demands of patient care. The New Hepatitis C is a current and essential review of HCV's epidemiology, diagnosis, and clinical approaches -- a clinician's guidebook for navigating everything from screening to treatment. Acute and chronic HCV are addressed, as are important new treatment options for HCV, management of side effects, and a convenient summary of clinical trials on the treatment of chronic hepatitis C. Updated to detail the standards of care that will define the next decade of HCV management, this evidence-based volume is an essential clinical reference for to any practitioner in gastroenterology, hepatology, infectious disease, transplant, or internal medicine.

Nancy Reau, MD, is Professor of Medicine, Chief of Hepatology, and Associate Director of Solid Organ Transplantation at Rush University Medical Center in Chicago. Donald M. Jensen, MD, is Professor of Medicine at Rush University Medical Center in Chicago.